Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer
<p dir="ltr">Cisplatin is a widely used platinum‐based chemotherapy agent. Its common adverse effects are neuropathy, nephrotoxicity, electrolyte abnormality, and rarely causing thrombotic vascular toxicity. We present a patient known to have small‐cell lung cancer who developed isch...
Saved in:
| Main Author: | Farah Rashid (13513911) (author) |
|---|---|
| Other Authors: | Nabil E. Omar (9545756) (author), Hassan Aaekl (21348284) (author), Ussama Al Homsi (14442150) (author), Alaaeldin Shablak (14778097) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
by: Reem Ali (9913494)
Published: (2022) -
Efficacy of Cannabidiol Combination with Cisplatin or Paclitaxel against Platinum-Resistant Ovarian Cancer Cell Lines
by: Ismail, Jana
Published: (2022) -
Determination of Medicago orbicularis Antioxidant, Antihemolytic, and Anti-Cancerous Activities and Its Augmentation of Cisplatin-Induced Cytotoxicity in A549 Lung Cancer Cells
by: Abdullah Shaito (20545181)
Published: (2024) -
Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke
by: Hoda Gad (6470522)
Published: (2019) -
Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
by: Iman W. Achkar (4246141)
Published: (2018)